56% of cancer patients reported suffering moderate to severe pain at least monthly, intrathecal drug delivery may help you.1

Chronic Pain
IDD info
lady with coffee

SIDE EFFECTS OF ORAL MEDICATION

drowsey
stomach
confusion
nausea

BY FINDING PAIN RELIEF AND REDUCING SIDE EFFECTS, YOU MAY FEEL BETTER. 

Intrathecal drug delivery aims to reduce uncontrolled cancer pain while minimising side effects, allowing you to experience each day with improved energy and quality of life.5,6,7

With intrathecal drug delivery you may manage breakthrough cancer pain 3 times faster compared to conventional medication.4

IS THIS THERAPY FOR ME?

IS INTRATHECAL DRUG DELIVERY AN OPTION FOR YOU?

Ask yourself the following questions:

therapy
opiods

If you answered ‘yes’ to one or both of these questions, talk to your clinician about intrathecal drug delivery therapy. 

pdf Cancer Pain Implant Support Brochure (.pdf)

Intrathecal drug delivery for managing chronic cancer refractory pain

988KB

pdf Cancer Pain Referral Brochure (.pdf)

Intrathecal drug delivery for managing chronic cancer refractory pain

1012KB

man with child

CONTROL YOUR PAIN REDISCOVER YOUR SMILE

REFERENCES

1

Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, Dow L, Cohen R. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Annals of Oncology 2009;20(8): 1420-33.

2

Caraceni, Augusto et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58-68.

3

Corli O, Floriani I, Roberto A, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicentre randomized phase IV ‘real life’ trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107–15.

4

Brogan SE, Winter NB, Okifuji A. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction. Regional Anesthesia and Pain Medicine 2015;40(4): 369-75.

5

Smith TJ, Staats PS, Deer T, Stearns LJ, et al. Randomized clinical trial of an implantable drug delivery (IDDS) system compared with comprehensive medical management (CMM) for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040-4049.

6

Smith TJ, Coyne PJ. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Pall Med. 2005;8(4):736-742.

7

Stearns L, Abd-Elsayed A, Perruchoud C, et. al. Intrathecal drug delivery systems for cancer pain: an analysis of a prospective, multicenter product surveillance registry. Anesthesia and Analgesia. 2019 Sep 18. doi: 10.1213/ANE.0000000000004425. [Epub ahead of print]